Johnson & Johnson Hit With $8 Billion Jury Verdict in Risperdal Suit by BY MIHIR ZAVERI AND KATIE THOMAS

This entry was posted in Health Weight Watchers and tagged Health NYT on by

A Philadelphia jury found that a subsidiary downplayed the risks that the anti-psychotic drug could lead to breast growth in boys.

Published: October 9, 2019 at 03:47AM

from NYT Health https://ift.tt/31YDhZP